| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medical and Physiological Chemistry, Uppsala University, Biomedical Center, Box 575, S-751 23 Uppsala [P. T., P. H.], and Departments of Lung Medicine [P. T.] and Oncology [J. B.], University Hospital, S-751 85 Uppsala, Sweden
We investigated the production of hyaluronan and the presence of hyaluronan receptors in a panel of human lung carcinoma cell lines, consisting of small cell carcinomas (SCLC) and non-small cell carcinomas (non-SCLC). These transformed cell lines produced only minute amounts of hyaluronan, whereas normal lung fibroblasts synthesized high amounts. CD44 molecules (an integral membrane glycoprotein suggested previously to function as a hyaluronan receptor) were differentially expressed on non-SCLC cell lines but essentially not on the SCLC cell lines. In contrast, RHAMM molecules (receptor for hyaluronan-mediated motility) were preferentially expressed on SCLC cells. Although all the lung tumor cell lines expressed various amounts of CD44 and RHAMM, only the SCLC line U-1752 could bind [3H]hyaluronan. The binding sites were saturated with about 19,700 hyaluronan molecules (Mr 1.4 x 106) bound per cell with a Kd of 0.16 x 10-9 M. CD44 molecules were responsible for the binding activity since Hermes-1 antibodies that block the binding of hyaluronan to CD44 blocked the binding of [3H]hyaluronan to U-1752 cells. 4-Phorbol 12-myristate 13-acetate (PMA) treatment of U-1752 cells both increased the hyaluronan-binding activity in U-1752 cells as well as induced abrogation of cell-cell and cell-matrix interactions. Addition of hyaluronan inhibited the PMA-induced disassembly of the cells. The fact that CD44 molecules are able to bind [3H]hyaluronan only on the SCLC line U-1752 but not on other lung carcinoma cell lines may be of value as a marker for squamous cell carcinoma differentiation. Furthermore, the inhibitory effect of hyaluronan on the PMA-promoted cell disassembly suggest that hyaluronan surrounding squamous cell carcinoma cells may affect their migration and invasiveness.
1 This project was supported in part by grants from The Swedish Cancer Society, Gustaf V:s 80-årsfond, The Swedish Medical Research Council (O3X-4), Göran Gustafssons Stiftelse, and the Medical Faculty of Uppsala University.
2 To whom requests for reprints should be addressed.
Received 4/ 4/95. Accepted 7/ 5/95.
This article has been cited by other articles:
![]() |
I Zlobec, L Terracciano, L Tornillo, U Gunthert, T Vuong, J R Jass, and A Lugli Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer Gut, October 1, 2008; 57(10): 1413 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, C.-H. Heldin, and P. Heldin Inhibition of Platelet-derived Growth Factor-BB-induced Receptor Activation and Fibroblast Migration by Hyaluronan Activation of CD44 J. Biol. Chem., September 8, 2006; 281(36): 26512 - 26519. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rodriguez-Rodriguez, I. Sancho-Torres, D. G. Gibbon, L. F. Miller Watelet, and C. Mesonero CD44-9v and CD44-10v Are Potential Molecular Markers for Squamous Cell Carcinoma of the Vulva Reproductive Sciences, January 1, 2000; 7(1): 70 - 75. [Abstract] [PDF] |
||||
![]() |
S. Kayastha, A. N., F. M., S. Piver, J. Mukkamalla, M. Romero-Guittierez, and B. A. Werness Expression of the Hyaluronan Receptor, CD44S, in Epithelial Ovarian Cancer Is an Independent Predictor of Survival Clin. Cancer Res., May 1, 1999; 5(5): 1073 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhang, M. C. Y. Chang, D. Zylka, S. Turley, R. Harrison, and E. A. Turley The Hyaluronan Receptor RHAMM Regulates Extracellular-regulated Kinase J. Biol. Chem., May 1, 1998; 273(18): 11342 - 11348. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Assmann, J. Marshall, C Fieber, M Hofmann, and I. Hart The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells J. Cell Sci., January 6, 1998; 111(12): 1685 - 1694. [Abstract] [PDF] |
||||
![]() |
V. B. Lokeshwar and M. G. Selzer Differences in Hyaluronic Acid-mediated Functions and Signaling in Arterial, Microvessel, and Vein-derived Human Endothelial Cells J. Biol. Chem., September 1, 2000; 275(36): 27641 - 27649. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |